Pharmaceutical composition for the treatment of hyperphosphatemia use of lanthanum carbonate process for the preparation of lanthanum carbonate and lanthanum carbonate

摘要

PCT No. PCT/GB96/00575 Sec. 371 Date Jan. 2, 1998 Sec. 102(e) Date Jan. 2, 1998 PCT Filed Mar. 19, 1996 PCT Pub. No. WO96/30029 PCT Pub. Date Oct. 3, 1996Selected lanthanum carbonate hydrates may be administered into the gastrointestinal tract, to treat hyperphosphataemia in patients with renal failure.